Table 3.
β-Catenin staining localization distribution in the different study groups.
| Localization | Only membrane | Membrane+cytoplasm | Membrane+cytoplasm+nucleus |
|---|---|---|---|
| Samples | |||
| ACC (n=11) | 18.18% (n=2) | 63.64% (n=7) | 18.18% (n=2) |
| ACAt (n=20) | 5.00% (n=1) | 65.00% (n=13) | 30.00% (n=6) |
| ACAc (n=7) | 0.00% (n=0) | 100.00% (n=7) | 0.00% (n=0) |
| ACAn (n=13) | 7.69% (n=1) | 46.15% (n=6) | 46.15% (n=6) |
| NAG (n=12) | 100.00% (n=12) | 0.00% (n=0) | 0.00% (n=0) |
ACC, adrenocortical carcinoma; ACAt, total adrenocortical adenoma; ACAc, adenoma with Cushing's syndrome; ACAn, nonfunctioning adenoma; NAG, normal adrenal gland.